| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10911-008-9097-1 |
| P8608 | Fatcat ID | release_bpbrbp4ea5gfljtun7nzu7bwzu |
| P698 | PubMed publication ID | 19002570 |
| P2093 | author name string | Robert A Jones | |
| Roger A Moorehead | |||
| P2860 | cites work | Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2 | Q24672372 |
| The protective role of pregnancy in breast cancer | Q24810274 | ||
| Epithelial-mesenchymal transitions in tumour progression | Q27860487 | ||
| The transcriptional repressor Snail promotes mammary tumor recurrence | Q28272823 | ||
| Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2 | Q28294068 | ||
| Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) | Q29619910 | ||
| Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin | Q31036521 | ||
| Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer | Q33890758 | ||
| A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology | Q34116752 | ||
| Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice | Q34342812 | ||
| P190-B Rho GTPase-activating protein overexpression disrupts ductal morphogenesis and induces hyperplastic lesions in the developing mammary gland | Q34493249 | ||
| Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene | Q34560337 | ||
| Transitions between epithelial and mesenchymal states in development and disease | Q34761972 | ||
| Type I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cells | Q35012773 | ||
| Isoform-specific ras activation and oncogene dependence during MYC- and Wnt-induced mammary tumorigenesis | Q35131418 | ||
| Insulin-like growth factors and breast cancer | Q35170250 | ||
| The insulin-like growth factor system in advanced breast cancer | Q35612304 | ||
| Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II) | Q36081417 | ||
| Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition | Q36320600 | ||
| Paracrine overexpression of insulin-like growth factor-1 enhances mammary tumorigenesis in vivo | Q36855753 | ||
| Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression. | Q36902961 | ||
| Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model | Q37354895 | ||
| ErbB2 is required for ductal morphogenesis of the mammary gland | Q37704948 | ||
| Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression | Q38287546 | ||
| Reversibility and recurrence of IGF-IR-induced mammary tumors | Q39859193 | ||
| Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptor. | Q39978258 | ||
| Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations | Q40086113 | ||
| Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor | Q40427703 | ||
| Type I insulin-like growth factor receptor function in breast cancer. | Q41727242 | ||
| Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snail | Q42738098 | ||
| The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number | Q42804213 | ||
| IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition | Q42826102 | ||
| Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds | Q43770402 | ||
| Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis | Q44259982 | ||
| Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950-69 | Q44274260 | ||
| Expression of ovine insulin-like growth factor-1 (IGF-1) stimulates alveolar bud development in mammary glands of transgenic mice | Q45113758 | ||
| Ductal growth is impeded in mammary glands of C-neu transgenic mice. | Q46014880 | ||
| Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer. | Q46268677 | ||
| Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. | Q53334281 | ||
| Protective effects of pregnancy and lactation against N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats. | Q53424173 | ||
| Increased Milk Yield in Transgenic Mice Expressing Insulin-like Growth Factor 1 | Q58294101 | ||
| Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes | Q70641455 | ||
| Insulin-like growth factor-I and insulin-like growth factor binding protein-3 inhibit involution of the mammary gland following lactation: studies in transgenic mice | Q71559313 | ||
| Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis | Q73510884 | ||
| Inability of overexpressed des(1-3)human insulin-like growth factor I (IGF-I) to inhibit forced mammary gland involution is associated with decreased expression of IGF signaling molecules | Q73620060 | ||
| Inhibition of mammary epithelial apoptosis and sustained phosphorylation of Akt/PKB in MMTV-IGF-II transgenic mice | Q73786615 | ||
| Metastasizing mammary carcinomas in H19 enhancers-Igf2 transgenic mice | Q74508495 | ||
| Transgenic hypersecretion of des(1-3) human insulin-like growth factor I in mouse milk has limited effects on the gastrointestinal tract in suckling pups | Q77897047 | ||
| Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation | Q80213822 | ||
| Overexpression of des(1-3) insulin-like growth factor 1 in the mammary glands of transgenic mice delays the loss of milk production with prolonged lactation | Q81002699 | ||
| Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation | Q81165932 | ||
| Expression of insulin-like growth factor-I receptor, estrogen receptor alpha, Bcl-2 and Bax proteins in human breast cancer | Q81828284 | ||
| P433 | issue | 4 | |
| P921 | main subject | overexpression | Q61643320 |
| P304 | page(s) | 407-413 | |
| P577 | publication date | 2008-11-11 | |
| P1433 | published in | Journal of Mammary Gland Biology and Neoplasia | Q15724460 |
| P1476 | title | The impact of transgenic IGF-IR overexpression on mammary development and tumorigenesis | |
| P478 | volume | 13 |
| Q34515619 | Association between insulin-like growth factor-1 receptor (IGF1R) negativity and poor prognosis in a cohort of women with primary breast cancer |
| Q45093278 | Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes |
| Q50766711 | Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer. |
| Q26860821 | Crosstalk of the Insulin-Like Growth Factor Receptor with the Wnt Signaling Pathway in Breast Cancer |
| Q34133760 | ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis |
| Q47143930 | Expression of insulin-like growth factor-1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes. |
| Q36251216 | Fetal alcohol exposure increases mammary tumor susceptibility and alters tumor phenotype in rats |
| Q34333651 | Golgi calcium pump secretory pathway calcium ATPase 1 (SPCA1) is a key regulator of insulin-like growth factor receptor (IGF1R) processing in the basal-like breast cancer cell line MDA-MB-231 |
| Q33916778 | IGF-I during primiparous pregnancy and maternal risk of breast cancer |
| Q34564798 | Inactivation of RARβ inhibits Wnt1-induced mammary tumorigenesis by suppressing epithelial-mesenchymal transitions. |
| Q90570117 | Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial |
| Q46014808 | Insulin-like growth factor-1 receptor gene expression is associated with survival in breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression. |
| Q38868797 | Low-fidelity alternative DNA repair carcinogenesis theory may interpret many cancer features and anticancer strategies |
| Q38221690 | Low-fidelity compensatory backup alternative DNA repair pathways may unify current carcinogenesis theories |
| Q36047389 | Osteopontin regulates proliferation, apoptosis, and migration of murine claudin-low mammary tumor cells |
| Q33707003 | Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells |
Search more.